Abstract
THE terms of the Report of the Royal Commission on Vaccination, published towards the end of the year 1896, made it evident that there was a general feeling on the part of the Commissioners that the use of calf lymph should be encouraged as far as possible; and it was patent to those who grasped the full significance of the Report, that in order to fall in with popular sentiment, even apart from other considerations, some effort would be made by those in authority to examine carefully into the claims advanced on behalf of calf lymph vaccination as carried out at home and in European countries. For some time past it has been recognised by those who have been cognisant of Dr. Monckton Copeman's work on the “glycerination” of vaccine lymph, and especially of that derived from the calf, that the advantages connected with the use of this lymph are of such a nature that many of the objections that have been urged against the use of calf lymph are practically eliminated. Although this work has been going on in our midst, it appears that, in order to obtain any knowledge of the practical outcome of Dr. Copeman's investigations, we are compelled to turn our attention to the large vaccine establishments of France, Germany, Belgium and Switzerland, where, under State control, the use of glycerinated calf lymph has now come to be recognised as the method, of all others, which is attended with the greatest success.
Article PDF
Rights and permissions
About this article
Cite this article
On the Use of Glycerinated Calf Lymph for Protective Vaccination against Small-Pox. Nature 57, 391–392 (1898). https://doi.org/10.1038/057391b0
Issue Date:
DOI: https://doi.org/10.1038/057391b0